Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Recurso digital |
| Taal: | |
| Gepubliceerd in: |
Zenodo
2025
|
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.5281/zenodo.17879015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Inhoudsopgave:
- In patients with atrial fibrillation and a history of intracranial hemorrhage, apixaban may be a suitable option among direct oral anticoagulants due to a potentially lower risk of bleeding, though definitive evidence from head-to-head trials is lacking.